{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:00:35Z","timestamp":1790388035517,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T00:00:00Z","timestamp":1236729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00018-009-0003-9","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T04:43:01Z","timestamp":1236660181000},"page":"2067-2073","source":"Crossref","is-referenced-by-count":44,"title":["Fibroblast growth factor 21: an overview from a clinical perspective"],"prefix":"10.1007","volume":"66","author":[{"given":"Mikael","family":"Ryd\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,11]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","volume":"16","author":"M Presta","year":"2005","unstructured":"Presta M, Dell\u2019Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16:159\u2013178","journal-title":"Cytokine Growth Factor Rev"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","volume":"20","author":"N Itoh","year":"2004","unstructured":"Itoh N, Ornitz DM (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563\u2013569","journal-title":"Trends Genet"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","volume":"1492","author":"T Nishimura","year":"2000","unstructured":"Nishimura T, Nakatake Y, Konishi M, Itoh N (2000) Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492:203\u2013206","journal-title":"Biochim Biophys Acta"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345\u2013348","journal-title":"Nat Genet"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500\u20136505","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","volume":"277","author":"T Yamashita","year":"2000","unstructured":"Yamashita T, Yoshioka M, Itoh N (2000) Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277:494\u2013498","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-4781(98)00255-3","volume":"1444","author":"T Nishimura","year":"1999","unstructured":"Nishimura T, Utsunomiya Y, Hoshikawa M, Ohuchi H, Itoh N (1999) Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta 1444:148\u2013151","journal-title":"Biochim Biophys Acta"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217\u2013225","journal-title":"Cell Metab"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","volume":"260","author":"T Lundasen","year":"2006","unstructured":"Lundasen T, Galman C, Angelin B, Rudling M (2006) Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 260:530\u2013536","journal-title":"J Intern Med"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bone.2006.12.062","volume":"40","author":"S Fukumoto","year":"2007","unstructured":"Fukumoto S, Yamashita T (2007) FGF23 is a hormone-regulating phosphate metabolism\u2013unique biological characteristics of FGF23. Bone 40:1190\u20131195","journal-title":"Bone"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115:1627\u20131635","journal-title":"J Clin Invest"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00063030-200822010-00004","volume":"22","author":"A Kharitonenkov","year":"2008","unstructured":"Kharitonenkov A, Shanafelt AB (2008) Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases. BioDrugs 22:37\u201344","journal-title":"BioDrugs"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","volume":"27","author":"R Goetz","year":"2007","unstructured":"Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, Kurosu H, Ogawa Y, Kuro-o M, Lanske B, Razzaque MS, Mohammadi M (2007) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 27:3417\u20133428","journal-title":"Mol Cell Biol"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/bi035320k","volume":"43","author":"NJ Harmer","year":"2004","unstructured":"Harmer NJ, Pellegrini L, Chirgadze D, Fernandez-Recio J, Blundell TL (2004) The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry 43:629\u2013640","journal-title":"Biochemistry"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120\u20136123","journal-title":"J Biol Chem"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770\u2013774","journal-title":"Nature"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","volume":"282","author":"H Kurosu","year":"2007","unstructured":"Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro-o M (2007) Tissue-specific expression of beta-Klotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282:26687\u201326695","journal-title":"J Biol Chem"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","volume":"104","author":"Y Ogawa","year":"2007","unstructured":"Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M, Kuro-o M (2007) BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci USA 104:7432\u20137437","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.21357","volume":"215","author":"A Kharitonenkov","year":"2008","unstructured":"Kharitonenkov A, Dunbar JD, Bina HA, Bright S, Moyers JS, Zhang C, Ding L, Micanovic R, Mehrbod SF, Knierman MD, Hale JE, Coskun T, Shanafelt AB (2008) FGF-21\/FGF-21 receptor interaction and activation is determined by betaKlotho. J Cell Physiol 215:1\u20137","journal-title":"J Cell Physiol"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/me.2007-0313","volume":"22","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi A, Oka S, Imamura T (2008) betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol Endocrinol 22:1006\u20131014","journal-title":"Mol Endocrinol"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0925-4773(00)00439-1","volume":"98","author":"S Ito","year":"2000","unstructured":"Ito S, Kinoshita S, Shiraishi N, Nakagawa S, Sekine S, Fujimori T, Nabeshima YI (2000) Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein. Mech Dev 98:115\u2013119","journal-title":"Mech Dev"},{"key":"3_CR22","doi-asserted-by":"crossref","unstructured":"Micanovic R, Raches DW, Dunbar JD, Driver DA, Bina HA, Dickinson CD, Kharitonenkov A (2008) Different roles of N- and C-termini in the functional activity of FGF21. J Cell Physiol 219:227\u2013234","DOI":"10.1002\/jcp.21675"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.febslet.2008.11.023","volume":"583","author":"J Yie","year":"2009","unstructured":"Yie J, Hecht R, Patel J, Stevens J, Wang W, Hawkins N, Steavenson S, Smith S, Winters D, Fisher S, Cai L, Belouski E, Chen C, Michaels ML, Li YS, Lindberg R, Wang M, Veniant M, Xu J (2009) FGF21 N- and C-termini play different roles in receptor interaction and activation. FEBS Lett 583:19\u201324","journal-title":"FEBS Lett"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","volume":"149","author":"T Coskun","year":"2008","unstructured":"Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE, Kharitonenkov A (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149:6018\u20136027","journal-title":"Endocrinology"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, Chen JL, Jung DY, Zhang Z, Ko HJ, Kim JK, Veniant MM (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58:250\u2013259","journal-title":"Diabetes"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","volume":"148","author":"A Kharitonenkov","year":"2007","unstructured":"Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB, Etgen GJ (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148:774\u2013781","journal-title":"Endocrinology"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2337\/db05-1435","volume":"55","author":"W Wente","year":"2006","unstructured":"Wente W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, Sandusky GE, Sewing S, Treinies I, Zitzer H, Gromada J (2006) Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase \u00bd and Akt signaling pathways. Diabetes 55:2470\u20132478","journal-title":"Diabetes"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","volume":"5","author":"MK Badman","year":"2007","unstructured":"Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E (2007) Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5:426\u2013437","journal-title":"Cell Metab"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, Kliewer SA (2007) Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5:415\u2013425","journal-title":"Cell Metab"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2007.05.010","volume":"5","author":"ML Reitman","year":"2007","unstructured":"Reitman ML (2007) FGF21: a missing link in the biology of fasting. Cell Metab 5:405\u2013407","journal-title":"Cell Metab"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","volume":"360","author":"T Lundasen","year":"2007","unstructured":"Lundasen T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE, Rudling M (2007) PPARalpha is a key regulator of hepatic FGF21. Biochem Biophys Res Commun 360:437\u2013440","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/mol.108.044826","volume":"74","author":"ES Muise","year":"2008","unstructured":"Muise ES, Azzolina B, Kuo DW, El-Sherbeini M, Tan Y, Yuan X, Mu J, Thompson JR, Berger JP, Wong KK (2008) Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol 74:403\u2013412","journal-title":"Mol Pharmacol"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/MCB.00992-07","volume":"28","author":"H Wang","year":"2008","unstructured":"Wang H, Qiang L, Farmer SR (2008) Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol 28:188\u2013200","journal-title":"Mol Cell Biol"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","volume":"582","author":"Y Izumiya","year":"2008","unstructured":"Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K (2008) FGF21 is an Akt-regulated myokine. FEBS Lett 582:3805\u20133810","journal-title":"FEBS Lett"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1152\/japplphysiol.01055.2004","volume":"98","author":"EJ Stevenson","year":"2005","unstructured":"Stevenson EJ, Koncarevic A, Giresi PG, Jackman RW, Kandarian SC (2005) Transcriptional profile of a myotube starvation model of atrophy. J Appl Physiol 98:1396\u20131406","journal-title":"J Appl Physiol"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.20847","volume":"210","author":"JS Moyers","year":"2007","unstructured":"Moyers JS, Shiyanova TL, Mehrbod F, Dunbar JD, Noblitt TW, Otto KA, Reifel-Miller A, Kharitonenkov A (2007) Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J Cell Physiol 210:1\u20136","journal-title":"J Cell Physiol"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS, Xu A (2008) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57:1246\u20131253","journal-title":"Diabetes"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","volume":"582","author":"P Arner","year":"2008","unstructured":"Arner P, Pettersson A, Mitchell PJ, Dunbar JD, Kharitonenkov A, Ryden M (2008) FGF21 attenuates lipolysis in human adipocytes\u2013a possible link to improved insulin sensitivity. FEBS Lett 582:1725\u20131730","journal-title":"FEBS Lett"},{"issue":"Suppl 2","key":"3_CR39","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/dmrr.254","volume":"18","author":"P Arner","year":"2002","unstructured":"Arner P (2002) Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 18[Suppl 2]:S5\u2013S9","journal-title":"Diabetes Metab Res Rev"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","volume":"8","author":"C Galman","year":"2008","unstructured":"Galman C, Lundasen T, Kharitonenkov A, Bina HA, Eriksson M, Hafstrom I, Dahlin M, Amark P, Angelin B, Rudling M (2008) The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab 8:169\u2013174","journal-title":"Cell Metab"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1210\/jc.2008-0746","volume":"93","author":"I Dostalova","year":"2008","unstructured":"Dostalova I, Kavalkova P, Haluzikova D, Lacinova Z, Mraz M, Papezova H, Haluzik M (2008) Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa. J Clin Endocrinol Metab 93:3627\u20133632","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diabres.2008.07.012","volume":"82","author":"L Li","year":"2008","unstructured":"Li L, Yang G, Ning H, Yang M, Liu H, Chen W (2008) Plasma FGF-21 levels in type 2 diabetic patients with ketosis. Diabetes Res Clin Pract 82:209\u2013213","journal-title":"Diabetes Res Clin Pract"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2337\/dc08-1054","volume":"32","author":"S Stein","year":"2009","unstructured":"Stein S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2009) Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care 32:126\u2013128","journal-title":"Diabetes Care"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nm0995-950","volume":"1","author":"F Lonnqvist","year":"1995","unstructured":"Lonnqvist F, Arner P, Nordfors L, Schalling M (1995) Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1:950\u2013953","journal-title":"Nat Med"},{"key":"3_CR45","first-page":"21","volume":"6","author":"S O\u2019Rahilly","year":"2001","unstructured":"O\u2019Rahilly S (2001) Leptin: pathophysiology and implications for therapy. Eat Weight Disord 6:21","journal-title":"Eat Weight Disord"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","volume":"341","author":"IS Farooqi","year":"1999","unstructured":"Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O\u2019Rahilly S (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879\u2013884","journal-title":"N Engl J Med"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-009-0003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-009-0003-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-009-0003-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:22:50Z","timestamp":1558520570000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-009-0003-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,11]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s00018-009-0003-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,11]]}}}